CAMBRIDGE, Mass.--(BUSINESS WIRE)--Curis, Inc. (NASDAQ: CRIS), a therapeutic drug development company focusing on cancer, neurological and dermatological disease indications, today announced that the company will be presenting at The Wall Street Analyst Forum Investor Conference taking place December 6th and 7th at The Princeton Club in New York, New York. The company will give its presentation on Thursday, December 7th, from 9:50 a.m. to 10:30 a.m. during the “Biotechnology & Healthcare” track.
